Pages that link to "Q73346458"

The following pages link to Influence of thyroid-stimulating hormone levels on uptake of FDG in recurrent and metastatic differentiated thyroid carcinoma (Q73346458):

Displaying 17 items.

• Recombinant TSH-stimulated, radioguided differentiated thyroid carcinoma surgery (Q33723307) (← links)
• Differentiated thyroid cancer: management of patients with radioiodine nonresponsive disease (Q35864072) (← links)
• Papillary thyroid cancer: medical management and follow-up (Q36168721) (← links)
• Clinical Usefulness of F-18 FDG PET/CT in Papillary Thyroid Cancer with Negative Radioiodine Scan and Elevated Thyroglobulin Level or Positive Anti-thyroglobulin Antibody (Q36910265) (← links)
• Role of ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography in patients affected by differentiated thyroid carcinoma, high thyroglobulin level, and negative ¹³¹I scan: review of the literature. (Q37813052) (← links)
• The role of 18F-fluorodeoxyglucose positron emission tomography in thyroid neoplasms (Q37850202) (← links)
• The Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in the Prognostication, Diagnosis, and Management of Thyroid Carcinoma (Q38658588) (← links)
• Detection of metastases from differentiated thyroid cancer by different imaging techniques (neck ultrasound, computed tomography and [18F]-FDG positron emission tomography) in patients with negative post-therapeutic ¹³¹I whole-body scan and detectab (Q42463071) (← links)
• Can calcification predict 131I accumulation on metastatic lymph nodes in papillary thyroid carcinoma patients receiving 131I therapy? Comparison of CT, 131I WBS and 18F-FDG PET/CT. (Q43281597) (← links)
• Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer (Q44687026) (← links)
• Influence of TSH on uptake of [18F]fluorodeoxyglucose in human thyroid cells in vitro (Q44727530) (← links)
• Optimal threshold of stimulated serum thyroglobulin level for 18F-FDG PET/CT imaging in patients with thyroid cancer. (Q52940648) (← links)
• The value of positron emission tomography in the surgical management of recurrent papillary thyroid carcinoma. (Q53440765) (← links)
• Risk factors of malignant fluorodeoxyglucose-avid lymph node on preablation positron emission tomography in patients with papillary thyroid cancer undergoing radioiodine ablation therapy (Q64238492) (← links)
• Combined PET/CT in the follow-up of differentiated thyroid carcinoma: what is the impact of each modality? (Q79356344) (← links)
• Comparison of 131I whole-body imaging, 131I SPECT/CT, and 18F-FDG PET/CT in the detection of metastatic thyroid cancer (Q83907836) (← links)
• Head-to-head comparison of F-18 FDG PET/CT in radioidine refractory thyroid cancer patients with elevated versus suppressed TSH levels a pilot study (Q90182663) (← links)